Manohar Vajja, MD
Internal Medicine · Dallas, TXNPI 1306048277
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
How this compares
$0 in reported general payments places this provider in the 10th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 36 | $602 |
| Memantine Hcl | 20 | $549 |
| Levetiracetam | 13 | $445 |
| ValacyclovirValacyclovir Hcl | 12 | $402 |
| Mirtazapine | 12 | $326 |
| Potassium Chloride | 21 | $303 |
| EnuloseLactulose | 12 | $282 |
| Donepezil Hcl | 21 | $276 |
| Metoprolol Succinate | 18 | $253 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $244 |
| Famotidine | 16 | $233 |
| Simvastatin | 11 | $153 |
| Levothyroxine Sodium | 20 | $141 |
| Amlodipine Besylate | 15 | $120 |
| Lisinopril | 11 | $116 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Dallas
- Amit VermaDallas$7.7M
- Valentine EbuhDallas$6.8M
- Gary SinclairDallas$3.4M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.